Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2013 - 2020)
Eledon Pharmaceuticals (ELDN) posted Depreciation & Amortization (CF) of $1000.0 for Q3 2020, down 50.0% on a QoQ basis from $2000.0 in Q2 2020, and down 66.67% year-over-year from $3000.0 in Q4 2019.
Eledon Pharmaceuticals (ELDN) Depreciation & Amortization (CF) (2013 - 2020) Analysis & Trends
Eledon Pharmaceuticals' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $1000.0 for Q3 2020.
- Quarterly Depreciation & Amortization (CF) fell 66.67% year-over-year to $1000.0 in Q3 2020, while the trailing twelve-month figure through Jun 2021 was $1000.0 (down 88.89% YoY) and the FY2020 annual result came in at $5000.0, down 44.44% from the prior year.
- Depreciation & Amortization (CF) was $1000.0 for Q3 2020 at Eledon Pharmaceuticals, down from $2000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $53000.0 in Q1 2016 and bottomed at -$4000.0 in Q3 2016.
- A 5-year average of $8789.5 and a median of $3000.0 in 2018 frame the typical range for Depreciation & Amortization (CF).
- Peak annual rise in Depreciation & Amortization (CF) reached 960.0% in 2016, while the deepest fall reached 112.5% in 2016.
- Eledon Pharmaceuticals' Depreciation & Amortization (CF) stood at $19000.0 in 2016, then plunged by 78.95% to $4000.0 in 2017, then slipped by 25.0% to $3000.0 in 2018, then slumped by 33.33% to $2000.0 in 2019, then plunged by 50.0% to $1000.0 in 2020.
- Business Quant data shows ELDN's Depreciation & Amortization (CF) at $1000.0 in Q3 2020, $2000.0 in Q2 2020, and $2000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,930.48 Bn | 1,930.42 Bn | - | - |
| 3 | Akari Therapeutics | 1,071.19 Bn | 1,071.19 Bn | - | - |
| 4 | BeOne Medicines | 468.55 Bn | 463.76 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 123.04 Bn | 115.79 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.31 Bn | 61.56 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 63.40 Bn | 63.40 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.67 Bn | 34.66 Bn | 959.66 Mn | - |
| 10 | Eledon Pharmaceuticals | 406.41 Mn | 406.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 1,000.00 |
| Sep 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Jun 30, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Jun 30, 2018 | 2,000.00 |